MAP1LC3A and thyroid gland undifferentiated (anaplastic) carcinoma: GANT61, a Gli1-specific inhibitor, induced LC3 lipidation in two anaplastic thyroid cancer cell lines, SW1736 (Fig. 1A) and KAT-18 cells (Fig. 1C), in a dose- and time-dependent manner.